nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimantadine—Hallucination—Lisinopril—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Rimantadine—Decreased appetite—Mometasone—systemic scleroderma	0.00353	0.00353	CcSEcCtD
Rimantadine—Shock—Captopril—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Rimantadine—Oedema peripheral—Lisinopril—systemic scleroderma	0.0035	0.0035	CcSEcCtD
Rimantadine—Fatigue—Mometasone—systemic scleroderma	0.0035	0.0035	CcSEcCtD
Rimantadine—Tachycardia—Captopril—systemic scleroderma	0.00348	0.00348	CcSEcCtD
Rimantadine—Depression—Mycophenolate mofetil—systemic scleroderma	0.00346	0.00346	CcSEcCtD
Rimantadine—Anorexia—Captopril—systemic scleroderma	0.0034	0.0034	CcSEcCtD
Rimantadine—Stomatitis—Mycophenolate mofetil—systemic scleroderma	0.00338	0.00338	CcSEcCtD
Rimantadine—Asthenia—Pentoxifylline—systemic scleroderma	0.00338	0.00338	CcSEcCtD
Rimantadine—Tension—Mycophenolic acid—systemic scleroderma	0.00337	0.00337	CcSEcCtD
Rimantadine—Nervousness—Mycophenolic acid—systemic scleroderma	0.00334	0.00334	CcSEcCtD
Rimantadine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Rimantadine—Tinnitus—Lisinopril—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Rimantadine—Insomnia—Captopril—systemic scleroderma	0.00323	0.00323	CcSEcCtD
Rimantadine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Rimantadine—Tremor—Mycophenolic acid—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Rimantadine—Abdominal pain—Mometasone—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Rimantadine—Chills—Lisinopril—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Rimantadine—Palpitations—Leflunomide—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Rimantadine—Dyspnoea—Captopril—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Rimantadine—Somnolence—Captopril—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Rimantadine—Agitation—Mycophenolic acid—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Rimantadine—Cough—Leflunomide—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Rimantadine—Dyspepsia—Captopril—systemic scleroderma	0.00314	0.00314	CcSEcCtD
Rimantadine—Cardiac failure—Prednisone—systemic scleroderma	0.00313	0.00313	CcSEcCtD
Rimantadine—Dizziness—Pentoxifylline—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Rimantadine—Hypertension—Leflunomide—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Rimantadine—Decreased appetite—Captopril—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Rimantadine—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Rimantadine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Rimantadine—Syncope—Mycophenolic acid—systemic scleroderma	0.00308	0.00308	CcSEcCtD
Rimantadine—Fatigue—Captopril—systemic scleroderma	0.00308	0.00308	CcSEcCtD
Rimantadine—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00307	0.00307	CcSEcCtD
Rimantadine—Anxiety—Leflunomide—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Rimantadine—Constipation—Captopril—systemic scleroderma	0.00305	0.00305	CcSEcCtD
Rimantadine—Tension—Lisinopril—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Rimantadine—Palpitations—Mycophenolic acid—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Rimantadine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Rimantadine—Nervousness—Lisinopril—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Rimantadine—Dry mouth—Leflunomide—systemic scleroderma	0.003	0.003	CcSEcCtD
Rimantadine—Cough—Mycophenolic acid—systemic scleroderma	0.003	0.003	CcSEcCtD
Rimantadine—Vomiting—Pentoxifylline—systemic scleroderma	0.00299	0.00299	CcSEcCtD
Rimantadine—Convulsion—Mycophenolic acid—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Rimantadine—Rash—Pentoxifylline—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Rimantadine—Hypertension—Mycophenolic acid—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Rimantadine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Rimantadine—Headache—Pentoxifylline—systemic scleroderma	0.00295	0.00295	CcSEcCtD
Rimantadine—Feeling abnormal—Captopril—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Rimantadine—Gastrointestinal pain—Captopril—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Rimantadine—Anxiety—Mycophenolic acid—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Rimantadine—Asthenia—Mometasone—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Rimantadine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00291	0.00291	CcSEcCtD
Rimantadine—Tremor—Lisinopril—systemic scleroderma	0.0029	0.0029	CcSEcCtD
Rimantadine—Tachycardia—Leflunomide—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Rimantadine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Rimantadine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00284	0.00284	CcSEcCtD
Rimantadine—Confusional state—Mycophenolic acid—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Rimantadine—Abdominal pain—Captopril—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Rimantadine—Anorexia—Leflunomide—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Rimantadine—Nausea—Pentoxifylline—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Rimantadine—Chills—Mycophenolate mofetil—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Rimantadine—Diarrhoea—Mometasone—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Rimantadine—Syncope—Lisinopril—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Rimantadine—Shock—Mycophenolic acid—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Rimantadine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Rimantadine—Palpitations—Lisinopril—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Rimantadine—Loss of consciousness—Lisinopril—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Rimantadine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Rimantadine—Cough—Lisinopril—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Rimantadine—Anorexia—Mycophenolic acid—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Rimantadine—Tension—Mycophenolate mofetil—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Rimantadine—Insomnia—Leflunomide—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Rimantadine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Rimantadine—Anxiety—Lisinopril—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Rimantadine—Dyspnoea—Leflunomide—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Rimantadine—Dyspepsia—Leflunomide—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Rimantadine—Vomiting—Mometasone—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Rimantadine—Dry mouth—Lisinopril—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Rimantadine—Sweating increased—Prednisone—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Rimantadine—Feeling abnormal—Azathioprine—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Rimantadine—Rash—Mometasone—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Rimantadine—Asthenia—Captopril—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Rimantadine—Dermatitis—Mometasone—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Rimantadine—Decreased appetite—Leflunomide—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Rimantadine—Confusional state—Lisinopril—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Rimantadine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Rimantadine—Headache—Mometasone—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Rimantadine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Rimantadine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Rimantadine—Fatigue—Leflunomide—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Rimantadine—Constipation—Leflunomide—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Rimantadine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Rimantadine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Rimantadine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Rimantadine—Shock—Lisinopril—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Rimantadine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Rimantadine—Tachycardia—Lisinopril—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Rimantadine—Abdominal pain—Azathioprine—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Rimantadine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Rimantadine—Diarrhoea—Captopril—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Rimantadine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Rimantadine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Rimantadine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Rimantadine—Fatigue—Mycophenolic acid—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Rimantadine—Nausea—Mometasone—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Rimantadine—Anorexia—Lisinopril—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Rimantadine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Rimantadine—Ataxia—Methotrexate—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Rimantadine—Constipation—Mycophenolic acid—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Rimantadine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Rimantadine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Rimantadine—Cough—Mycophenolate mofetil—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Rimantadine—Dizziness—Captopril—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Rimantadine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Rimantadine—Depression—Prednisone—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Rimantadine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Rimantadine—Abdominal pain—Leflunomide—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Rimantadine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Rimantadine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Rimantadine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Rimantadine—Insomnia—Lisinopril—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Rimantadine—Vomiting—Captopril—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Rimantadine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Rimantadine—Dyspnoea—Lisinopril—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Rimantadine—Rash—Captopril—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Rimantadine—Dermatitis—Captopril—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Rimantadine—Somnolence—Lisinopril—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Rimantadine—Headache—Captopril—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Rimantadine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Rimantadine—Dyspepsia—Lisinopril—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Rimantadine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Rimantadine—Decreased appetite—Lisinopril—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Rimantadine—Fatigue—Lisinopril—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Rimantadine—Shock—Mycophenolate mofetil—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Rimantadine—Constipation—Lisinopril—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Rimantadine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Rimantadine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Rimantadine—Diarrhoea—Azathioprine—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Rimantadine—Nausea—Captopril—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Rimantadine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Rimantadine—Asthenia—Leflunomide—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Rimantadine—Hallucination—Prednisone—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Rimantadine—Feeling abnormal—Lisinopril—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Rimantadine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Rimantadine—Dizziness—Azathioprine—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Rimantadine—Asthenia—Mycophenolic acid—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Rimantadine—Diarrhoea—Leflunomide—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Rimantadine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.002	0.002	CcSEcCtD
Rimantadine—Abdominal pain—Lisinopril—systemic scleroderma	0.002	0.002	CcSEcCtD
Rimantadine—Vomiting—Azathioprine—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Rimantadine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Rimantadine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Rimantadine—Rash—Azathioprine—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Rimantadine—Dermatitis—Azathioprine—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Rimantadine—Depression—Methotrexate—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Rimantadine—Headache—Azathioprine—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Rimantadine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Rimantadine—Dizziness—Leflunomide—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Rimantadine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Rimantadine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Rimantadine—Stomatitis—Methotrexate—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Rimantadine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Rimantadine—Vomiting—Leflunomide—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Rimantadine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Rimantadine—Rash—Leflunomide—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Rimantadine—Dermatitis—Leflunomide—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Rimantadine—Nausea—Azathioprine—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Rimantadine—Headache—Leflunomide—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Rimantadine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Rimantadine—Asthenia—Lisinopril—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Rimantadine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Rimantadine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Rimantadine—Rash—Mycophenolic acid—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Rimantadine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Rimantadine—Headache—Mycophenolic acid—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Rimantadine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Rimantadine—Nausea—Leflunomide—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Rimantadine—Diarrhoea—Lisinopril—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Rimantadine—Agitation—Prednisone—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Rimantadine—Dizziness—Lisinopril—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Rimantadine—Nausea—Mycophenolic acid—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Rimantadine—Syncope—Prednisone—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Rimantadine—Tinnitus—Methotrexate—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Rimantadine—Loss of consciousness—Prednisone—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Rimantadine—Vomiting—Lisinopril—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Rimantadine—Rash—Lisinopril—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Rimantadine—Convulsion—Prednisone—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Rimantadine—Dermatitis—Lisinopril—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Rimantadine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Rimantadine—Hypertension—Prednisone—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Rimantadine—Chills—Methotrexate—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Rimantadine—Headache—Lisinopril—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Rimantadine—Anxiety—Prednisone—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Rimantadine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Rimantadine—Nausea—Lisinopril—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Rimantadine—Shock—Prednisone—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Rimantadine—Tachycardia—Prednisone—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Rimantadine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Rimantadine—Hyperhidrosis—Prednisone—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Rimantadine—Anorexia—Prednisone—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Rimantadine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Rimantadine—Rash—Mycophenolate mofetil—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Rimantadine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Rimantadine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Rimantadine—Insomnia—Prednisone—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Rimantadine—Cough—Methotrexate—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Rimantadine—Convulsion—Methotrexate—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Rimantadine—Dyspepsia—Prednisone—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Rimantadine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Rimantadine—Decreased appetite—Prednisone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Rimantadine—Fatigue—Prednisone—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Rimantadine—Constipation—Prednisone—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Rimantadine—Confusional state—Methotrexate—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Rimantadine—Feeling abnormal—Prednisone—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Rimantadine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Rimantadine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Rimantadine—Anorexia—Methotrexate—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Rimantadine—Abdominal pain—Prednisone—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Rimantadine—Insomnia—Methotrexate—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Rimantadine—Dyspnoea—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Rimantadine—Somnolence—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Rimantadine—Dyspepsia—Methotrexate—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Rimantadine—Decreased appetite—Methotrexate—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Rimantadine—Fatigue—Methotrexate—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Rimantadine—Asthenia—Prednisone—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Rimantadine—Feeling abnormal—Methotrexate—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Rimantadine—Diarrhoea—Prednisone—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Rimantadine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Rimantadine—Dizziness—Prednisone—systemic scleroderma	0.000993	0.000993	CcSEcCtD
Rimantadine—Abdominal pain—Methotrexate—systemic scleroderma	0.000992	0.000992	CcSEcCtD
Rimantadine—Vomiting—Prednisone—systemic scleroderma	0.000954	0.000954	CcSEcCtD
Rimantadine—Rash—Prednisone—systemic scleroderma	0.000946	0.000946	CcSEcCtD
Rimantadine—Dermatitis—Prednisone—systemic scleroderma	0.000946	0.000946	CcSEcCtD
Rimantadine—Headache—Prednisone—systemic scleroderma	0.00094	0.00094	CcSEcCtD
Rimantadine—Asthenia—Methotrexate—systemic scleroderma	0.0009	0.0009	CcSEcCtD
Rimantadine—Nausea—Prednisone—systemic scleroderma	0.000892	0.000892	CcSEcCtD
Rimantadine—Diarrhoea—Methotrexate—systemic scleroderma	0.000858	0.000858	CcSEcCtD
Rimantadine—Dizziness—Methotrexate—systemic scleroderma	0.00083	0.00083	CcSEcCtD
Rimantadine—Vomiting—Methotrexate—systemic scleroderma	0.000798	0.000798	CcSEcCtD
Rimantadine—Rash—Methotrexate—systemic scleroderma	0.000791	0.000791	CcSEcCtD
Rimantadine—Dermatitis—Methotrexate—systemic scleroderma	0.00079	0.00079	CcSEcCtD
Rimantadine—Headache—Methotrexate—systemic scleroderma	0.000786	0.000786	CcSEcCtD
Rimantadine—Nausea—Methotrexate—systemic scleroderma	0.000745	0.000745	CcSEcCtD
